163 results
Page 4 of 9
8-K
EX-99.1
ff9pno2yz2n5r9
5 Nov 20
FibroGen Reports THIRD Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
w987w
6 Aug 20
FibroGen Reports SECOND Quarter 2020 Financial Results
4:10pm
8-K
EX-99.1
oyk cz7q3d6
6 Aug 20
FibroGen Announces New Appointments to its Board of Directors
4:06pm
8-K
EX-99.1
94hng3v8c85
7 May 20
FibroGen Reports First Quarter 2020 Financial Results
4:09pm
8-K
EX-99.1
2xdhdu w3
24 Mar 20
Master Supply Agreement
5:24pm
8-K
EX-99.1
vrj u0qi0f
2 Mar 20
FibroGen Reports Fourth Quarter and Full Year 2019 Financial Results
4:06pm
8-K
kndnxztuvjr4y yt
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
ysialcb
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
4bctct sn
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
wi4zci4h
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
hxkw12zv
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
6pe1bdv
6 Jan 20
Fibrogen Names Enrique Conterno As Chief Executive Officer
5:23pm
8-K
EX-99.1
tqqtt0
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
8-K
f88 w6scj5tuknz0o
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am